HLA-DR Expression on Monocyte Subsets in Critically Ill Children
暂无分享,去创建一个
G. Van den Berghe | G. Driessen | J. Hazelzet | W. Dik | N. Nagtzaam | I. Vanhorebeek | N. P. Boeddha | K. Joosten | D. Kerklaan | A. Dunbar | E. van Puffelen | S. Verbruggen | N. Boeddha
[1] R. Hotchkiss,et al. Comparison of monocyte human leukocyte antigen-DR expression and stimulated tumor necrosis factor alpha production as outcome predictors in severe sepsis: a prospective observational study , 2016, Critical Care.
[2] E. Troster,et al. Prolonged suppression of monocytic human leukocyte antigen-DR expression correlates with mortality in pediatric septic patients in a pediatric tertiary Intensive Care Unit. , 2016, Journal of critical care.
[3] G. Van den Berghe,et al. Early versus Late Parenteral Nutrition in Critically Ill Children. , 2016, The New England journal of medicine.
[4] M. Weigand,et al. Sepsis-induced long-term immune paralysis – results of a descriptive, explorative study , 2016, Critical Care.
[5] M. Netea,et al. Interferon-gamma Immunotherapy in a Patient With Refractory Disseminated Candidiasis , 2015, The Pediatric infectious disease journal.
[6] G. Van den Berghe,et al. Impact of withholding early parenteral nutrition completing enteral nutrition in pediatric critically ill patients (PEPaNIC trial): study protocol for a randomized controlled trial , 2015, Trials.
[7] M. Hofbeck,et al. Patterns of monocyte subpopulations and their surface expression of HLA-DR during adverse events after hematopoietic stem cell transplantation , 2015, Annals of Hematology.
[8] M. Hofbeck,et al. Human leukocyte antigen DR surface expression on CD14+ monocytes during adverse events after hematopoietic stem cell transplantation , 2015, Annals of Hematology.
[9] R. Hotchkiss,et al. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy , 2013, Nature Reviews Immunology.
[10] J. Talmadge,et al. History of myeloid-derived suppressor cells , 2013, Nature Reviews Cancer.
[11] R. Curi,et al. Parenteral fish oil as a pharmacological agent to modulate post-operative immune response: a randomized, double-blind, and controlled clinical trial in patients with gastrointestinal cancer. , 2013, Clinical nutrition.
[12] R. Hotchkiss,et al. Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies. , 2013, Current opinion in immunology.
[13] M. Netea,et al. Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change? , 2013, American journal of respiratory and critical care medicine.
[14] R. Hotchkiss,et al. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. , 2013, The Lancet. Infectious diseases.
[15] J. Timsit,et al. Inter‐laboratory assessment of flow cytometric monocyte HLA‐DR expression in clinical samples , 2013, Cytometry. Part B, Clinical cytometry.
[16] D. Fliser,et al. Monocyte heterogeneity in human cardiovascular disease. , 2012, Immunobiology.
[17] T. Kalina,et al. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols , 2012, Leukemia.
[18] L. Moldawer,et al. Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care , 2012, The journal of trauma and acute care surgery.
[19] M. Manz,et al. Demand-adapted regulation of early hematopoiesis in infection and inflammation. , 2012, Blood.
[20] S. Wong,et al. The three human monocyte subsets: implications for health and disease , 2012, Immunologic Research.
[21] F. Venet,et al. Clinical review: flow cytometry perspectives in the ICU - from diagnosis of infection to monitoring of injury-induced immune dysfunctions , 2011, Critical care.
[22] Wing-Cheong Wong,et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. , 2011, Blood.
[23] Y. Dou,et al. Epigenetic regulation of immune cell functions during post-septic immunosuppression , 2011, Epigenetics.
[24] Lyle L. Moldawer,et al. A Paradoxical Role for Myeloid-Derived Suppressor Cells in Sepsis and Trauma , 2011, Molecular medicine.
[25] Silvano Sozzani,et al. Nomenclature of monocytes and dendritic cells in blood. , 2010, Blood.
[26] N. Voirin,et al. Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock , 2010, Intensive Care Medicine.
[27] F. Tacke,et al. Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults , 2010, BMC Immunology.
[28] P. Pronovost,et al. Long-term mortality and quality of life in sepsis: A systematic review* , 2010, Critical care medicine.
[29] T. Baumann,et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. , 2009, American journal of respiratory and critical care medicine.
[30] Margaret A Dudeck,et al. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.
[31] M. Zembala,et al. Peripheral Blood CD14high CD16+ Monocytes are Main Producers of IL‐10 , 2008, Scandinavian journal of immunology.
[32] D. Mosser,et al. Monocyte subpopulations and their differentiation patterns during infection , 2007, Journal of leukocyte biology.
[33] N. Voirin,et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock , 2006, Intensive Care Medicine.
[34] G. Wanten. An update on parenteral lipids and immune function: only smoke, or is there any fire? , 2006, Current opinion in clinical nutrition and metabolic care.
[35] C. Meisel,et al. Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study. , 2005, Clinical chemistry.
[36] I. Chaudry,et al. Surgical trauma and immunosuppression: pathophysiology and potential immunomodulatory approaches , 2005, Langenbeck's Archives of Surgery.
[37] V. Rousson,et al. Monocyte function-associated antigen expression during and after pediatric cardiac surgery. , 2005, The Journal of thoracic and cardiovascular surgery.
[38] Alain Martinot,et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study , 2003, The Lancet.
[39] C. Nebe,et al. Age-related Low Expression of HLA-DR Molecules on Monocytes of Term and Preterm Newborns With and Without Signs of Infection , 2003, Journal of Perinatology.
[40] I. Chaudry,et al. The cellular basis of post-burn immunosuppression: macrophages and mediators. , 2002, International journal of molecular medicine.
[41] J. Pryjma,et al. CD14+CD16+ Monocytes in the Course of Sepsis in Neonates and Small Children: Monitoring and Functional Studies , 2002, Scandinavian journal of immunology.
[42] R. Callard,et al. Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care* , 2002, Critical care medicine.
[43] K. Asadullah,et al. Monocyte deactivation in septic patients: Restoration by IFN-γ treatment , 1997, Nature Medicine.
[44] K. Asadullah,et al. Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: proof of principle. , 1997, Archives of internal medicine.
[45] C. Gogos,et al. Total parenteral nutrition and immune system activity: a review. , 1995, Nutrition.